Defining the role of G3BP1 in vascular development
Active Project Grant Awarded Last action
- Award ID
- F31HL177906
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $191,584
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 44% complete
- Place of performance
- New Haven, CT 06510, USA
Award details come from USAspending.gov.
Description
- Abstract
- Proper blood vessel formation is essential for delivering blood to organs and tissues, crucial for their development and function. However, aberrant blood vessel formation is associated with diverse pathologies including tumor development and fibrotic scarring. Therefore, IT is critical to understand the gene regulatory networks underlying blood vessel formation so that these networks can be effectively manipulated during pathological processes as a therapeutic approach. While great strides have been made in recent years to uncover key mechanisms of transcriptional regulation in blood vessel development, relatively little is known regarding post-transcriptional mechanisms that operate during this process. Post-transcriptional regulation serves as the ultimate gatekeeper of protein output within a cell and thus is essential for cellular function during tissue formation. RNA binding proteins (rbps) bind directly to mrna to control their stability, decay, and translation into protein, and many rbps have been correlated with highly angiogenic tumors. Yet, while rbps represent promising therapeutic targets, virtually nothing is known regarding roles for rbps in the formation of blood vessels. Evidently, investigating how rbps regulate blood vessel formation through post-transcriptional regulation will enhance our understanding of the gene regulatory networks underlying blood vessel formation in health and disease. The overall objective of this study is to define the role of the RBP G3BP1 in blood vessel formation. G3BP1 interacts with various components of translational machinery, influencing protein synthesis dynamics in cells. Dysregulation of G3BP1-mediated translation has been implicated in various diseases, including cancer and neurodegenerative disorders, but its role in regulating blood vessel formation remains unknown. I developed a novel G3BP1 loss-of-function mutant zebrafish that exhibit aberrant blood vessel formation. This sets the foundation to tackle the following key questions: (1) what is the role of G3BP1 in blood vessel formation? (2) is G3BP1 regulating blood vessel formation via interactions with translational machinery? To answer these questions, we will utilize high resolution live imaging of developing blood vessels in zebrafish embryos, tissue-specific protein degradation technology in vivo, 2D and 3D primary human cell culture assays, and omics approaches to measure mrna translation and the G3BP1 protein interactome. This project will reveal G3BP1's role as anew regulator of blood vessel formationand will thus inform how its function contributes to aberrant blood vessel formation in disease contexts, which may ultimately be manipulated for therapeutic gain.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $38,098 | |
| Amendment | $3,000 | |
| Amendment | $3,000 | |
| Amendment | $564 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $48,974 | |
| Amendment | $48,974 | |
| Original award | $48,974 |
Quick answers
Who received award F31HL177906?
F31HL177906 was awarded to Yale Univ by National Heart Lung and Blood Institute (National Institutes of Health) on July 15, 2025.
How much is award F31HL177906 worth?
$191,584 has been obligated on F31HL177906.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award